Abnormal Cannabidiols for lowering intraocular pressure

Details for Australian Patent Application No. 2005262652 (hide)

Owner Allergan, Inc.

Inventors Woodward, David F.; Chen, June

Agent Davies Collison Cave

Pub. Number AU-A-2005262652

PCT Pub. Number WO2006/007227

Priority 11/073,209 05.03.05 US; 11/121,528 02.05.05 US; 10/874,441 22.06.04 US; 10/874,440 22.06.04 US

Filing date 26 May 2005

Wipo publication date 19 January 2006

International Classifications

A61K 31/05 (2006.01)

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/007227 Priority application(s): WO2006/007227

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005262655-C-shaped disc prosthesis

2005262637-Fire resistant PV shingle assembly